Orelabrutinib
Orelabrutinib is an orally active and irreversible inhibitor of Bruton's tyrosine kinase (BTK) . (In Vitro) :With a proprietary formulation, Orelabrutinib (ICP-022) achieves high bioavailability comparing to other BTK inhibitors. (In Vivo) :Upon administration, Orelabrutinib (ICP-022) binds to and inhibits the activity of BTK. This prevents both the activation of the B-cell antigen receptor (BCR) signaling pathway and BTK-mediated activation of downstream survival pathways, inhibiting the growth of malignant B-cells that overexpress BTK.
Product Specifications
CAS Number
1655504-04-3
Product Name Alternative
ICP-022
Purity
>98% (HPLC)
Solubility
DMSO:250 mg/mL (584.80 mM; Need ultrasonic)
Smiles
NC (=O) c1ccc (nc1-c1ccc (Oc2ccccc2) cc1) C1CCN (CC1) C (=O) C=C
Molecular Formula
C26H25N3O3
Molecular Weight
427.5
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
